You are searching for: hsa04510

---

T01851 Target Info	Target Name	Integrin beta-1 (ITGB1)
	Target type	Clinical trial Target
	Disease	Non-small-cell lung cancer; Glioblastoma of brain;
	Drugs	131I-radretumab	Drug Info

T05031 Target Info	Target Name	PI3-kinase beta (PIK3CB)
	Target type	Clinical trial Target
	Disease	Breast cancer; Squamous head and neck cell carcinom;
	Drugs	Buparlisib	Drug Info

T40276 Target Info	Target Name	Protein kinase C beta (PRKCB)
	Target type	Clinical trial Target
	Disease	Diffuse large B-cell lymphoma; Lymphoma;
	Drugs	Enzastaurin	Drug Info

T06093 Target Info	Target Name	Rho-associated protein kinase 2 (ROCK2)
	Target type	Successful Target
	Disease	Graft-versus-host disease; Psoriasis vulgaris;
	Drugs	Belumosudil	Drug Info

T84780 Target Info	Target Name	Cellular inhibitor of apoptosis 1 (BIRC2)
	Target type	Clinical trial Target
	Disease	Squamous head and neck cell carcinom; Lymphoma;
	Drugs	AT-406	Drug Info

T35173 Target Info	Target Name	Cellular inhibitor of apoptosis 2 (BIRC3)
	Target type	Clinical trial Target
	Disease	Squamous head and neck cell carcinom; Solid tumour/cancer;
	Drugs	AT-406	Drug Info

T23276 Target Info	Target Name	Extracellular signal-regulated kinase 1 (ERK1)
	Target type	Clinical trial Target
	Disease	Melanoma; Artery stenosis;
	Drugs	BVD-523	Drug Info

T12355 Target Info	Target Name	G1/S-specific cyclin-D1 (CCND1)
	Target type	Clinical trial Target
	Disease	Myelofibrosis; Relapsed or refractory chronic lymphocytic leukaemia;
	Drugs	ABT-263	Drug Info

T55293 Target Info	Target Name	Integrin alpha-2 (ITGA2)
	Target type	Clinical trial Target
	Disease	Colorectal cancer; Solid tumour/cancer;
	Drugs	E7820	Drug Info

T97141 Target Info	Target Name	Myosin light kinase (MYLK)
	Target type	Clinical trial Target
	Disease	Duodenal ulcer;
	Drugs	ME-3407	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.